Artigos de revistas sobre o tema "DLT alternatives de consortium"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "DLT alternatives de consortium".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Monje, Michelle, Tabitha Cooney, John Glod, Jie Huang, Patricia Baxter, Anna Vinitsky, Lindsay Kilburn et al. "DIPG-10. A Phase I trial of panobinostat following radiation therapy in children with diffuse intrinsic pontine glioma (DIPG) or H3K27M-mutated thalamic diffuse midline glioma (DMG): Report from the Pediatric Brain Tumor Consortium (PBTC-047)". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i19—i20. http://dx.doi.org/10.1093/neuonc/noac079.067.
Texto completo da fonteShah, Nirali N., Sarah K. Tasian, M. Eric Kohler, Emily M. Hsieh, Susanne H. C. Baumeister, Corinne Summers, Haneen Shalabi et al. "CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial". Blood 142, Supplement 1 (28 de novembro de 2023): 771. http://dx.doi.org/10.1182/blood-2023-179667.
Texto completo da fonteEbben, John, Jens C. Eickhoff, Dustin A. Deming, Howard S. Hochster, Anita Ahmed Turk, Vaibhav Sahai e Nataliya Volodymyrivna Uboha. "QUIC: Phase 2 study of gemcitabine, cisplatin, quemliclustat (AB680), and zimberelimab (AB122) during first-line treatment of advanced biliary tract cancers (BTC)—Big Ten Cancer Research Consortium study BTCRC-GI22-564." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): TPS4195. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps4195.
Texto completo da fonteIslam, Md Rafiqul, Muhammad Mahbubur Rahman, Mohammed Ataur Rahman, Muslin Har Sani Mohamad e Abd Halim Embang. "A Review on Blockchain Technology for Distribution of Energy". International Journal of Engineering Materials and Manufacture 7, n.º 2 (22 de abril de 2022): 61–70. http://dx.doi.org/10.26776/ijemm.07.02.2022.03.
Texto completo da fontePoh, Christina, Paul Frankel, Christopher Ruel, Mehrdad Abedi, Emily Schwab, Caitlin L. Costello, Jasmine Zain et al. "Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis". Blood 134, Supplement_1 (13 de novembro de 2019): 760. http://dx.doi.org/10.1182/blood-2019-124254.
Texto completo da fontePhadke, Sneha, Kari Wisinski, Oana Danciu, Ami Shah, Menggang Yu, Yi Chen, Kathy Miller e Mark Burkard. "Abstract PO1-06-09: Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast CancersBig Ten Cancer Research Consortium BTCRC-BRE18-337". Cancer Research 84, n.º 9_Supplement (2 de maio de 2024): PO1–06–09—PO1–06–09. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-06-09.
Texto completo da fonteWen, P. Y., T. Cloughesy, J. Kuhn, K. Lamborn, L. E. Abrey, F. Lieberman, H. I. Robins, J. Wright, M. D. Prados e M. Gilbert. "Phase I/II study of sorafenib and temsirolimus for patients with recurrent glioblastoma (GBM) (NABTC 05–02)". Journal of Clinical Oncology 27, n.º 15_suppl (20 de maio de 2009): 2006. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2006.
Texto completo da fonteMinard, Charles Gene, Rachel Rau, Susan Hilsenbeck, Brenda J. Weigel, Elizabeth Fox, Peter Adamson e Susan Blaney. "3488 A comparison between the Rolling 6 and 3+3 dose escalation study designs for phase 1 clinical trials". Journal of Clinical and Translational Science 3, s1 (março de 2019): 30–31. http://dx.doi.org/10.1017/cts.2019.73.
Texto completo da fonteGuo, Dong, e Peng Zhou. "The Evolution of Financial Market Infrastructure: From Digitalization to Tokenization". International Journal of Innovation and Entrepreneurship 2, n.º 1 (8 de março de 2023): 1. http://dx.doi.org/10.56502/ijie2010002.
Texto completo da fonteMthethwa, Sthembile, e Morne Pretorius. "Academic and Skills Credentialing Using Distributed Ledger Technology (DLT) and W3C Standards: Technology Assessment". International Conference on Intelligent and Innovative Computing Applications 2022 (31 de dezembro de 2022): 170–82. http://dx.doi.org/10.59200/iconic.2022.019.
Texto completo da fonteGerring, John, e Daniel Pemstein. "Proposal: A Political Science Peer Review and Publication Consortium". PS: Political Science & Politics 54, n.º 1 (28 de outubro de 2020): 126–30. http://dx.doi.org/10.1017/s104909652000102x.
Texto completo da fonteAntal, Claudia, Tudor Cioara, Ionut Anghel, Marcel Antal e Ioan Salomie. "Distributed Ledger Technology Review and Decentralized Applications Development Guidelines". Future Internet 13, n.º 3 (27 de fevereiro de 2021): 62. http://dx.doi.org/10.3390/fi13030062.
Texto completo da fonteMohrbacher, Ann, Min H. Kang, Allen S. Yang, Susan G. Groshen, Lori Vergara, Martin Gutierrez, Anthony J. Murgo et al. "Phase I trial of fenretinide (4-HPR) intravenous emulsion in hematologic malignancies: A California Cancer Consortium study (PhI-42)." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 8073. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8073.
Texto completo da fonteBerg, S. L., H. Russell, M. Cairo, A. M. Ingle, P. C. Adamson e S. M. Blaney. "Phase I and pharmacokinetic (PK) study of lenalidomide (LEN) in pediatric patients with relapsed/refractory solid tumors or myelodysplastic syndrome (MDS): A Children's Oncology Group Phase I Consortium study". Journal of Clinical Oncology 27, n.º 15_suppl (20 de maio de 2009): 10023. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10023.
Texto completo da fonteBurke, Michael J., Patrick Brown, Richard Sposto, Lia Gore e Alan S. Wayne. "Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium". Blood 128, n.º 22 (2 de dezembro de 2016): 2781. http://dx.doi.org/10.1182/blood.v128.22.2781.2781.
Texto completo da fonteKleinberg, Lawrence, Jeffrey G. Supko, Tom Mikkelsen, Jaishri O'Neill Blakeley, Glen Stevens, Xiaobu Ye, Serena Desideri et al. "Phase I adult brain tumor consortium (ABTC) trial of ABT-888 (veliparib), temozolomide (TMZ), and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM) including pharmacokinetic (PK) data." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 2065. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2065.
Texto completo da fonteCombi, Romina, Maria Salsone, Chiara Villa e Luigi Ferini-Strambi. "Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges". International Journal of Molecular Sciences 22, n.º 8 (12 de abril de 2021): 3960. http://dx.doi.org/10.3390/ijms22083960.
Texto completo da fonteAplenc, Richard, Susan M. Blaney, Lewis C. Strauss, Frank M. Balis, Suzanne Shusterman, Ashish Mark Ingle, Shruti Agrawal, Junfeng Sun, John J. Wright e Peter C. Adamson. "Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium". Journal of Clinical Oncology 29, n.º 7 (1 de março de 2011): 839–44. http://dx.doi.org/10.1200/jco.2010.30.7231.
Texto completo da fonteOlanrewaju, Oluwaseyi Samuel, e Olubukola Oluranti Babalola. "Bacterial Consortium for Improved Maize (Zea mays L.) Production". Microorganisms 7, n.º 11 (1 de novembro de 2019): 519. http://dx.doi.org/10.3390/microorganisms7110519.
Texto completo da fonteLeichman, Lawrence P., Bert H. O'Neil, Jordan Berlin, Colin D. Weekes, Patricia Ames, Marti McKinley, Angela M. Davies e Steven J. Cohen. "A phase IB study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: An Academic GI Cancer Consortium (AGICC) study." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 4052. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4052.
Texto completo da fonteHinrichs, Richard N., e Scott P. McLean. "NLT and extrapolated DLT: 3-D cinematography alternatives for enlarging the volume of calibration". Journal of Biomechanics 28, n.º 10 (outubro de 1995): 1219–23. http://dx.doi.org/10.1016/0021-9290(95)00034-f.
Texto completo da fonteSomlo, George, Joseph A. Sparano, Tessa Cigler, Gini F. Fleming, Thehang H. Luu, Arti Hurria, Joanne E. Mortimer et al. "ABT-888 (veliparib) in combination with carboplatin in patients with stage IV BRCA-associated breast cancer. A California Cancer Consortium Trial." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 1010. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1010.
Texto completo da fonteLedwaba, Lehlogonolo P. I., Gerhard P. Hancke, Sherrin J. Isaac e Hein S. Venter. "Smart Microgrid Energy Market: Evaluating Distributed Ledger Technologies for Remote and Constrained Microgrid Deployments". Electronics 10, n.º 6 (18 de março de 2021): 714. http://dx.doi.org/10.3390/electronics10060714.
Texto completo da fonteWagner, L. M., J. P. Perentesis, J. M. Reid, M. M. Ames, S. L. Safgren, M. D. Nelson, A. M. Ingle, S. M. Blaney e P. C. Adamson. "Phase I trial and pharmacokinetic study of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with refractory solid tumors: A Children's Oncology Group Phase I Consortium study". Journal of Clinical Oncology 27, n.º 15_suppl (20 de maio de 2009): 10017. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10017.
Texto completo da fonteDelgado, Ninoska, Matías Olivera, Fabiola Cádiz, Guillermo Bravo, Iván Montenegro, Alejandro Madrid, Claudia Fuentealba, Romina Pedreschi, Eduardo Salgado e Ximena Besoain. "Volatile Organic Compounds (VOCs) Produced by Gluconobacter cerinus and Hanseniaspora osmophila Displaying Control Effect against Table Grape-Rot Pathogens". Antibiotics 10, n.º 6 (1 de junho de 2021): 663. http://dx.doi.org/10.3390/antibiotics10060663.
Texto completo da fonteGoldsmith, Kelly C., Kimberly Kayser, Susan G. Groshen, Marc Chioda, Holger C. Thurm, Joseph Chen, Gerson Peltz et al. "Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma: A New Approaches to Neuroblastoma Consortium study." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): 10504. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.10504.
Texto completo da fonteWidemann, B. C., E. Fox, P. C. Adamson, S. Baruchel, A. Kim, A. M. Ingle, J. Glade Bender, D. Stempak, F. M. Balis e S. M. Blaney. "Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial". Journal of Clinical Oncology 27, n.º 15_suppl (20 de maio de 2009): 10012. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10012.
Texto completo da fonteHan, Lei, Andreja Kutnar, Jakub Sandak, Iztok Šušteršič e Dick Sandberg. "Adhesive- and Metal-Free Assembly Techniques for Prefabricated Multi-Layer Engineered Wood Products: A Review on Wooden Connectors". Forests 14, n.º 2 (5 de fevereiro de 2023): 311. http://dx.doi.org/10.3390/f14020311.
Texto completo da fonteMosse, Yael P., Frank M. Balis, Megan S. Lim, Julie Laliberte, Stephan D. Voss, Elizabeth Fox, Rochelle Bagatell et al. "Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 9500. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9500.
Texto completo da fonteMorris, Michael J., Justine Yang Bruce, Leonard M. Reyno, Banmeet Anand, Alan Hartford, Kathy Jelaca-Maxwell, Jacqueline Lackey e Mario A. Eisenberger. "Phase I trial of ASG-5ME in metastatic castration-resistant prostate cancer (CRPC)." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 4568. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4568.
Texto completo da fonteLim, Michael, Xiaobu Ye, Anna F. Piotrowski, Arati Suvas Desai, Manmeet Singh Ahluwalia, Tobias Walbert, Joy D. Fisher et al. "Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM." Journal of Clinical Oncology 37, n.º 15_suppl (20 de maio de 2019): 2017. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2017.
Texto completo da fonteChumsri, Saranya, Sharmila Giri, Andrew Ness, David W. Hillman, Nadine Norton, Davitte Cogen, Edward Famularo et al. "Safety run-in phase of the multi-epitope HER2 peptide vaccine in combination with trastuzumab emtansine in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): 550. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.550.
Texto completo da fonteMehra, Sameer, Annette M. Harte, Adeayo Sotayo, Zhongwei Guan e Conan O’Ceallaigh. "Experimental investigation on the effect of accelerated ageing conditions on the pull-out capacity of compressed wood and hardwood dowel type fasteners". Holzforschung 76, n.º 1 (1 de janeiro de 2021): 89–98. http://dx.doi.org/10.1515/hf-2021-0097.
Texto completo da fonteCotoras, Davor, Cristian Hurtado e Pabla Viedma. "Integrated Sulfate Reduction and Biosorption Process for the Treatment of Mine Drainages". Solid State Phenomena 262 (agosto de 2017): 582–86. http://dx.doi.org/10.4028/www.scientific.net/ssp.262.582.
Texto completo da fonteHammoud, Obadah, Ivan Tarkhanov e Artyom Kosmarski. "An Architecture for Distributed Electronic Documents Storage in Decentralized Blockchain B2B Applications". Computers 10, n.º 11 (4 de novembro de 2021): 142. http://dx.doi.org/10.3390/computers10110142.
Texto completo da fonteDeWire, Mariko, Christine Fuller, Olivia Campagne, Tong Lin, Haitao Pan, Tina Young-Pussaint, Patricia Baxter et al. "EPCT-17. A PHASE I AND SURGICAL STUDY OF RIBOCICLIB AND EVEROLIMUS IN CHILDREN WITH RECURRENT OR REFRACTORY MALIGNANT BRAIN TUMORS: PEDIATRIC BRAIN TUMOR CONSORTIUM INTERIM REPORT". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii307. http://dx.doi.org/10.1093/neuonc/noaa222.139.
Texto completo da fonteLeary, Sarah, Julie R. Park, Joel M. Reid, Andrew T. Ralya, Sylvain Baruchel, Bing Wu, Ashish M. Ingle, Charlotte H. Ahern, Brenda Weigel e Susan Blaney. "A phase I trial and pharmacokinetic study of trebananib (AMG386) in children with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 Consortium report." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 2538. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2538.
Texto completo da fonteMatthay, Katherine K., Jessica C. Tan, Judith G. Villablanca, Gregory A. Yanik, Janet Veatch, Benjamin Franc, Eilish Twomey et al. "Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study". Journal of Clinical Oncology 24, n.º 3 (20 de janeiro de 2006): 500–506. http://dx.doi.org/10.1200/jco.2005.03.6400.
Texto completo da fonteVan Mater, David, Sridharan Gururangan, Sarah Leary, Oren Becher, Joanna Phillips, Jie Huang, Olivia Campagne et al. "EPCT-05. A PHASE I TRIAL OF THE CDK 4/6 INHIBITOR PALBOCICLIB IN PEDIATRIC PATIENTS WITH PROGRESSIVE OR REFRACTORY CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii304. http://dx.doi.org/10.1093/neuonc/noaa222.129.
Texto completo da fonteElhalis, Hosam, Xin Yi See, Raffael Osen, Xin Hui Chin e Yvonne Chow. "Significance of Fermentation in Plant-Based Meat Analogs: A Critical Review of Nutrition, and Safety-Related Aspects". Foods 12, n.º 17 (27 de agosto de 2023): 3222. http://dx.doi.org/10.3390/foods12173222.
Texto completo da fonteArgumedo-Delira, Rosalba, Mario J. Gómez-Martínez e Brenda Joan Soto. "Gold Bioleaching from Printed Circuit Boards of Mobile Phones by Aspergillus niger in a Culture without Agitation and with Glucose as a Carbon Source". Metals 9, n.º 5 (7 de maio de 2019): 521. http://dx.doi.org/10.3390/met9050521.
Texto completo da fonteMora-Salguero, Daniela, Martha Josefina Vives Florez, Johanna Husserl Orjuela, Miguel Fernández-Niño e Andrés Fernando González Barrios. "Evaluation of the phenol degradation capacity of microalgae-bacteria consortia from the bay of Cartagena, Colombia". TecnoLógicas 22, n.º 44 (15 de janeiro de 2019): 149–58. http://dx.doi.org/10.22430/22565337.1179.
Texto completo da fonteCairo, Mitchell S., Erin Cooney, Mark Krailo, Richard Belanger, Sherrie L. Perkins, Rashid Fawwaz, Anne Angiolillo e Peter Adamson. "A Phase I Study of 90Y-Ibritumomab-Tiuxetan (90Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study." Blood 106, n.º 11 (16 de novembro de 2005): 2448. http://dx.doi.org/10.1182/blood.v106.11.2448.2448.
Texto completo da fonteAlSkaif, Tarek, Bart Holthuizen, Wouter Schram, Ioannis Lampropoulos e Wilfried van Sark. "A Blockchain-Based Configuration for Balancing the Electricity Grid with Distributed Assets". World Electric Vehicle Journal 11, n.º 4 (30 de setembro de 2020): 62. http://dx.doi.org/10.3390/wevj11040062.
Texto completo da fonteVaravallo, Giuseppe, Giuseppe Caragnano, Fabrizio Bertone, Luca Vernetti-Prot e Olivier Terzo. "Traceability Platform Based on Green Blockchain: An Application Case Study in Dairy Supply Chain". Sustainability 14, n.º 6 (11 de março de 2022): 3321. http://dx.doi.org/10.3390/su14063321.
Texto completo da fonteNetto, G., A. Armstrong, D. Wood, P. Creel, A. Partin, A. Jimeno, M. Rudek, D. George, R. Gurganus e M. A. Carducci. "Pharmacodynamic (PD) study of pre-prostatectomy rapamycin in men with advanced localized prostate cancer (PC): A DOD Prostate Cancer Clinical Trials Consortium Trial". Journal of Clinical Oncology 27, n.º 15_suppl (20 de maio de 2009): 5001. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5001.
Texto completo da fonteWeingart, Jon, Stuart A. Grossman, Kathryn A. Carson, Joy D. Fisher, Shannon M. Delaney, Mark L. Rosenblum, Alessandro Olivi, Kevin Judy, Stephen B. Tatter e M. Eileen Dolan. "Phase I Trial of Polifeprosan 20 With Carmustine Implant Plus Continuous Infusion of Intravenous O6-Benzylguanine in Adults With Recurrent Malignant Glioma: New Approaches to Brain Tumor Therapy CNS Consortium Trial". Journal of Clinical Oncology 25, n.º 4 (1 de fevereiro de 2007): 399–404. http://dx.doi.org/10.1200/jco.2006.06.6290.
Texto completo da fontePedrotti, Carine, Clarissa Franzoi, Rafael Nicolas Sandi, Daniel Santos Grohs e Joséli Schwambach. "Eucalyptus staigeriana essential oil can control downy mildew in grapevine". Pesquisa Agropecuária Gaúcha 28, n.º 1 (27 de dezembro de 2021): 1–14. http://dx.doi.org/10.36812/pag.20222811-14.
Texto completo da fonteDale, Michael J., e Carl Sanniti. "Litigation as an Instrument for Change in Juvenile Detention: A Case Study". Crime & Delinquency 39, n.º 1 (janeiro de 1993): 49–67. http://dx.doi.org/10.1177/0011128793039001004.
Texto completo da fonteHoldhoff, Matthias, Stuart A. Grossman, Jeffrey G. Supko, Xiaobu Ye, Joy D. Fisher, Serena Desideri, Richard L. Wahl e David Schiff. "Sequential therapy with the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas: An Adult Brain Tumor Consortium phase I study (ABTC1101)." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): TPS2105. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.tps2105.
Texto completo da fonte